{"id":3144,"date":"2026-03-17T15:17:42","date_gmt":"2026-03-17T15:17:42","guid":{"rendered":"https:\/\/catalisquebec.com\/?post_type=news&#038;p=3144"},"modified":"2026-03-19T15:58:50","modified_gmt":"2026-03-19T15:58:50","slug":"chus-first-world-rare-inflammatory-disease-study","status":"publish","type":"news","link":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/","title":{"rendered":"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":3145,"template":"","news_category":[24,9],"class_list":["post-3144","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease - CATALIS Qu\u00e9bec<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease - CATALIS Qu\u00e9bec\" \/>\n<meta property=\"og:url\" content=\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/\" \/>\n<meta property=\"og:site_name\" content=\"CATALIS Qu\u00e9bec\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T15:58:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1760\" \/>\n\t<meta property=\"og:image:height\" content=\"1088\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/\",\"url\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/\",\"name\":\"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease - CATALIS Qu\u00e9bec\",\"isPartOf\":{\"@id\":\"https:\/\/catalisquebec.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png\",\"datePublished\":\"2026-03-17T15:17:42+00:00\",\"dateModified\":\"2026-03-19T15:58:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#primaryimage\",\"url\":\"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png\",\"contentUrl\":\"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png\",\"width\":1760,\"height\":1088},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/catalisquebec.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/catalisquebec.com\/en\/#website\",\"url\":\"https:\/\/catalisquebec.com\/en\/\",\"name\":\"CATALIS Qu\u00e9bec\",\"description\":\"Optimizing Clinical Research in Quebec: Our Priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/catalisquebec.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease - CATALIS Qu\u00e9bec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/","og_locale":"en_US","og_type":"article","og_title":"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease - CATALIS Qu\u00e9bec","og_url":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/","og_site_name":"CATALIS Qu\u00e9bec","article_modified_time":"2026-03-19T15:58:50+00:00","og_image":[{"width":1760,"height":1088,"url":"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/","url":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/","name":"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease - CATALIS Qu\u00e9bec","isPartOf":{"@id":"https:\/\/catalisquebec.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#primaryimage"},"image":{"@id":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#primaryimage"},"thumbnailUrl":"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png","datePublished":"2026-03-17T15:17:42+00:00","dateModified":"2026-03-19T15:58:50+00:00","breadcrumb":{"@id":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#primaryimage","url":"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png","contentUrl":"https:\/\/catalisquebec.com\/wp-content\/uploads\/2026\/03\/FT_Sanofi_EN.png","width":1760,"height":1088},{"@type":"BreadcrumbList","@id":"https:\/\/catalisquebec.com\/en\/news\/chus-first-world-rare-inflammatory-disease-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/catalisquebec.com\/en\/"},{"@type":"ListItem","position":2,"name":"The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease"}]},{"@type":"WebSite","@id":"https:\/\/catalisquebec.com\/en\/#website","url":"https:\/\/catalisquebec.com\/en\/","name":"CATALIS Qu\u00e9bec","description":"Optimizing Clinical Research in Quebec: Our Priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/catalisquebec.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/news\/3144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/users\/2"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/media\/3145"}],"wp:attachment":[{"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/media?parent=3144"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/catalisquebec.com\/en\/wp-json\/wp\/v2\/news_category?post=3144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}